前列腺特异性膜抗原放射引导手术检测接受机器人辅助根治性前列腺切除术及扩大盆腔淋巴结清扫的原发性前列腺癌患者的淋巴结转移:一项前瞻性2期研究的计划期中分析结果
这项前瞻性2期研究计划纳入100例中高危cN0cM0前列腺癌患者,2021年6月至2022年3月共入组18例,其中12例接受PSMA放射引导手术并构成研究队列。结果显示该手术安全可行,特异性可接受但敏感性欠佳,可能遗漏微转移淋巴结病变。
要点
- 12例患者中3例(25%)在扩大盆腔淋巴结清扫中证实淋巴结转移。
- 按区域分析96个淋巴结区,PSMA放射引导手术敏感性63%、特异性99%。
- 按患者分析敏感性67%、特异性100%,可能遗漏微转移淋巴结病变。
核心结论
- 机器人辅助PSMA放射引导手术用于原发分期安全可行,特异性可接受但敏感性欠佳,会遗漏微转移淋巴结病变。
研究设计与样本
- 前瞻性2期研究(NCT04832958),计划入组100例常规影像为中高危cN0cM0且淋巴结侵犯风险>5%的前列腺癌患者,2021年6月至2022年3月共入组18例,其中12例接受PSMA放射引导手术并构成研究队列。
主要发现
- 4例(33%)为中危、6例(50%)为高危、2例(17%)为局部晚期前列腺癌。
- 2例(17%)患者在PSMA PET上显示病理性淋巴结摄取。
- 中位手术时间230 min、出血量100 ml、住院时间5 d。
- 无不良事件和术中并发症记录;1例(8.3%)发生30天并发症(Clavien-Dindo 2级)。
- 3例(25%)患者在扩大盆腔淋巴结清扫中证实淋巴结转移。
关键数值与推荐
- 按区域分析96个淋巴结区,PSMA放射引导手术的敏感性63%、特异性99%、阳性预测值83%、阴性预测值96%。
- 按患者分析,PSMA放射引导手术的敏感性67%、特异性100%、阳性预测值100%、阴性预测值90%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Extended pelvic nodal dissection (ePLND) represents the gold standard for nodal staging in prostate cancer (PCa). Prostate-specific membrane antigen (PSMA) radioguided surgery (RGS) could identify lymph node invasion (LNI) during robot-assisted radical prostatectomy (RARP). OBJECTIVE: To report the planned interim analyses of a phase 2 prospective study (NCT04832958) aimed at describing PSMA-RGS during RARP. DESIGN, SETTING, AND PARTICIPANTS: A phase 2 trial aimed at enrolling 100 patients with intermediate- or high-risk cN0cM0 PCa at conventional imaging with a risk of LNI of >5% was conducted. Overall, 18 patients were enrolled between June 2021 and March 2022. Among them, 12 patients underwent PSMA-RGS and represented the study cohort. SURGICAL PROCEDURE: All patients received 68Ga-PSMA positron emission tomography (PET)/magnetic resonance imaging; 99mTc-PSMA-I&S was synthesised and administered intravenously the day before surgery, followed by single-photon emission computed tomography/computed tomography. A Drop-In gamma probe was used for in vivo measurements. All positive lesions (count rate ≥2 compared with background) were excised and ePLND was performed. MEASUREMENTS: Side effects, perioperative outcomes, and performance characteristics of robot-assisted PSMA-RGS for LNI were measured. RESULTS AND LIMITATIONS: Overall, four (33%), six (50%), and two (17%) patients had intermediate-risk, high-risk, and locally advanced PCa. Overall, two (17%) patients had pathologic nodal uptake at PSMA PET. The median operative time, blood loss, and length of stay were 230 min, 100 ml, and 5 d, respectively. No adverse events and intraoperative complications were recorded. One patient experienced a 30-d complication (Clavien-Dindo 2; 8.3%). Overall, three (25%) patients had LNI at ePLND. At per-region analyses on 96 nodal areas, sensitivity, specificity, positive predictive value, and negative predictive value of PSMA-RGS were 63%, 99%, 83%, and 96%, respectively. On a per-patient level, sensitivity, specificity, positive predictive value, and negative predictive values of PSMA-RGS were 67%, 100%, 100%, and 90%, respectively. CONCLUSIONS: Robot-assisted PSMA-RGS in primary staging is a safe and feasible procedure characterised by acceptable specificity but suboptimal sensitivity, missing micrometastatic nodal disease. PATIENT SUMMARY: Prostate-specific membrane antigen radioguided robot-assisted surgery is a safe and feasible procedure for the intraoperative identification of nodal metastases in cN0cM0 prostate cancer patients undergoing robot-assisted radical prostatectomy with extended pelvic lymph node dissection. However, this approach might still miss micrometastatic nodal dissemination.
引用
- Gandaglia G, Mazzone E, Stabile A, et al. Prostate-specific membrane antigen Radioguided Surgery to Detect Nodal Metastases in Primary Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Planned Interim Analysis of a Prospective Phase 2 Study. Eur Urol. 2022. PMID: 35879127. doi:10.1016/j.eururo.2022.06.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。